GRUNELABS = INNOVATION

HIGH
QUALITY

Biotechnology

The objective of GrüneLabs is the production of special medicines to treat neurological diseases and other pathologies.

LOCATIONS

We are located in Uruguay and Portugal

URUGUAY

Click Here

PORTUGAL

Click Here

WHO WE ARE

GrüneLabs is a pharmaceutical laboratory which seeks innovation in the processing of botanical specialties for the production of medicines with high technology, for children, adult and veterinary uses.

BIOTECHNOLOGY

We combine biotechnology and pharmaceuticals to achieve high quality products.

INNOVATION

The innovative merit of the project is the procurement of cannabis oils for the treatment of various diseases.

Z

OBJECTIVE

To generate an extract that serves as raw material for the development of medicinal products.

Cultivation

Cloning – The first stage of the production cycle begins with the proper propagation of the seedlings, taking care of the genetic profile and thus achieving standardization in the crop.

Vegetative – In the second stage of the cycle, the plants are transferred to the vegetation rooms where they develop increasing their foliar area, preparing for the entry to prayer.

Flowering – The company has the necessary facilities that allow the plants to qualify for their different growth stages, accompanied by a traceability system from the beginning.

Drying – The harvested material is received in the vegetative area to be dried and properly vacuum packed.

Laboratory

The laboratory has state-of-the-art machinery operated by a team of trained professionals. In it, the process of extraction of cannabis based on carbon dioxide (CO2) is carried out, achieving a product of unique quality in the industry.

Our Latest Work

We combine biotechnology and pharmaceuticals to achieve high quality products.

OUR PRODUCTS

MEROFLEX

Meroflex is a highly standardized pharmaceutical product derived from two chemovars of Cannabis sativa, predominantly CBD in a ratio of 2: 1 to THC.

Learn More

MEET OUR TEAM

Helicopter aviator, founder and director of the first cannabinoid pharmaceutical laboratory in South America.

João Paulo Rocha has expertise in designing and building complex high-tech but functional and profitable industrial structures for the pharmaceutical industry specialized in cannabis.

Currently under construction and subsequent management of another GruneLabs laboratory with a capacity 10 times higher than the previous one in Portugal, he spends his free time studying the benefits of the plant and the new technologies for cultivation, extraction and processing of pharmaceutical and cosmetic products.

Joao Paulo Rocha

Director de Operaciones (COO), Grunelabs

Businessman, with operations in Brazil, Uruguay and Portugal.

One of the pioneering entrepreneurs in the medical cannabis industry in Uruguay. Partner and CEO of the Grunelabs Group.

Sergio Merofa

Director Ejecutivo (CEO), Grunelabs

ASOCIACIÓN BATAR

Let’s Start Something new

CONTACT US